Abi Siva, Associate Professor and Director of Medical Oncology at MUSC Health Hematology Oncology at Hollings Cancer Center, shared a post by Sarah Sammons, Breast Medical Oncologist and Senior Physician at Dana-Farber’s Breast Oncology Center, on X, adding:
“Agree with Sarah Sammons.
The key question is how TDXd + P induction followed by ER-guided maintenance will perform. Ongoing studies will help answer this.”
Sarah Sammons: Helpful Thoughts on 1st Line HER2+ Metastatic Breast Cancer
